Abstract mRNA-based vaccines are emerging as a promising alternative to standard cancer
treatments and the conventional vaccines. Moreover, the FDA-approval of three nucleic acid …

Probiotics, the health-promoting members of the gut microbiota, have been shown to
enhance mucosal and systemic immunity, stimulate cytokines, chemokines, and antibodies …

Colorectal cancer (CRC) ranks among the most prevalent cancers globally, demanding
innovative therapeutic strategies. Immunotherapy, a promising avenue, employs cancer …

mRNA-lipid nanoparticle (LNP) medicinal products can be considered a platform technology
because the development process is similar for different diseases and conditions, with …

Prostate cancer, a prevalent malignancy affecting the prostate gland, is a significant global
health concern. Androgen-deprivation therapy (ADT) has proven effective in controlling …

The origins of cancer vaccines date back to the 1800s. Since then, there have been
significant efforts to generate vaccines against solid and hematologic malignancies using a …

Cancer remains one of the global leading causes of death and various vaccines have been
developed over the years against it, including cell-based, nucleic acid-based, and viral …

The central dogma of biology, which delineates the flow of genetic information from DNA to
RNA to protein, along with the principles of cellular immunology, provides a foundational …

Cancer vaccines based on tumor cell components have shown promising results in animal
and clinical studies. The vaccine system contains abundant tumor antigen components …

Human papillomavirus type 16 (HPV16) infection is responsible for more than 50% of global
cervical cancer cases. The development of a vaccine based on cytotoxic T-lymphocyte (CTL) …